Sudarshan Pharma Industries Ltd Share Price

Chemicals

BSE: 543828 Small Cap ISIN: INE00TV01023

As on 18 July 2026 at 17:03 IST

₹35

-0.07

(-0.20%)

Sell Buy

Over 1 Month

16.51%

Over 6 Months

43.97%

Over 1 Year

12.33%

Over 3 Years

437.06%

Sudarshan Pharma Industries Ltd Summary

Close ₹35.07

Open ₹35

High ₹35.50

Low ₹35

Volume 1,84,000

Net Turnover (in Cr) ₹0.64

52Wk High ₹36.95

52Wk Low ₹18.50

52Wk High / Low

18.50

36.95

Sudarshan Pharma Industries Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹843.99

EPS (TTM) 0.91

Book Value (BV) 6.35

Div. Yield -

P/E (TTM) 38.54

Price/Book Value 5.53

Delivery % 100 %

Face Value 1

Key Ratios

PE Ratio 46.27

PB Ratio 5.76

EV to Sales 1.81

PEG Ratio -0.54

ROA 5.21

ROE 14.79

Debt-Equity 1.15

Net Profit Margin 3.58

Operating Profit Margin 8.23

Sudarshan Pharma Industries Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	507.57	466.15	462.45	357.56	193.73
Total Expenses	483.12	450.92	452.95	350.42	190.15
Profit Before Tax	21.63	15.23	9.50	7.14	3.57
Profit After Tax	15.95	11.46	7.04	5.25	2.67
Operating Profit After Depreciation	40.22	24.17	14.90	10.51	6.80

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	23.87	25.50	19.89	6.47	6.21
Total Non Current Assets	67.56	45.91	33.86	7.94	11.62
Total Current Assets	334.85	237.22	198.62	129.58	87.64
Total Assets	402.41	283.13	232.48	137.52	99.26
Total Shareholder's Fund	131.48	111.71	100.97	29.78	22.51

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	35.22	7.75	-28.79	-3.82	2.77
Net Cash Used In Investing Activities	-20.37	-7.23	-25.65	-1.46	-1.29
Net Cash Used In Financing Activities	-14.45	-12.10	65.93	4.26	-1.49

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	505.38	468.31	462.45	357.56	193.62
Total Expenses	481.28	453.22	452.95	350.42	190.04
Profit Before Tax	21.29	15.10	9.50	7.14	3.58
Profit After Tax	15.88	11.36	7.04	5.25	2.67
Operating Profit After Depreciation	40.07	24.13	14.90	10.52	6.80

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	19.79	20.57	19.89	6.47	6.21
Total Non Current Assets	66.57	43.99	33.96	8.04	11.67
Total Current Assets	333.83	240.85	198.51	129.47	87.54
Total Assets	400.40	284.84	232.47	137.51	99.21
Total Shareholder's Fund	131.31	111.61	100.98	29.78	22.51

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	34.91	9.69	-28.79	-3.70	2.87
Net Cash Used In Investing Activities	-20.24	-9.08	-25.65	-1.54	-1.35
Net Cash Used In Financing Activities	-14.41	-12.18	65.93	4.31	-1.64

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	220.92	168.01	168.87	145.26	161.59
Total Expenses	200.73	157.14	159.66	134.22	145.67
Profit Before Tax	15.70	5.20	4.23	5.41	9.88
Profit After Tax	11.39	4.15	3.87	3.96	7.41
Operating Profit after Depreciation	24.32	12.39	11.07	12.25	16.76

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	199.81	158.37	167.01	142.31	161.57
Total Expenses	181.51	147.59	157.39	132.03	146.35
Profit Before Tax	13.24	5.42	4.83	5.19	9.28
Profit After Tax	9.54	4.31	4.40	3.73	7.03
Operating Profit after Depreciation	21.51	12.47	11.71	11.69	16.13

Sudarshan Pharma Industries Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 34.88

S2 34.69

S3 34.38

Pivot 35.19

R1 35.38

R2 35.69

R3 35.88

Moving Average

20 SMA 33.68

50 SMA 31.15

100 SMA 27.46

200 SMA 27.45

Sudarshan Pharma Industries Ltd Corporate Actions

Sudarshan Pharma Industries Ltd

₹0.3/Share

Announcement Date 25 Aug 2023

Record Date 26 Aug 2023

Div Yield 3%

AGM Date: 02 Sep 2023

The Board of Directors at its Meeting held on July 21, 2023 approved the agendas contained in the outcome. Due to restriction on character limit, the Outcome of the Board meeting is attached in the PDF format for your records. The Company intends to intimate to the Stock Exchange that with reference to the captioned subject matter, this letter is in continuation to the letter dated SPIL/CS/SE/2023-2024/05 to further inform you certain changes and that a Meeting of Board of Directors of the company was held on July 21, 2023 (As Per BSE Announcement dated on 26.07.2023) Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the dispatch of the Annual Report for the Financial Year ended 2022-2023 which includes AGM Notice and commencement of the 15th Annual General Meeting on 02nd September, 2023 at 4.00 P.M through VC/ OAVM. (As Per BSE Announcement dated on 10.08.2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Pursuant to Regulation 30 of SEBI (LIsting Obligations And Disclosure Requirements) Regulation, 2015, we enclose herewith the proceedings of the 16th Annual General Meeting of the Company held today, 30/Sep/2024 at 3.00 p.m. through video conferencing / other audio video means. (As per BSE Announcement dated on 30/09/2024) We enclose herewith the Voting Results of the 16th Annual General Meeting of the Company held on Monday, 30th September 2024 at 3.00 pm through video conferencing / other audio visual means. (As Per BSE Announcement Dated on 01.10.2024)

AGM Date: 25 Jul 2025

AGM 25/07/2025 Please find enclosed the newspaper advertisements for teh Notice of 17th Annual General Meeting of the Company published in (i) Mumbai Lakshdeep and (ii) Financial Express. (As Per BSE Announcement dated on 02.07.2025) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Proceedings of the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 at 3.00 p.m. IST through video conferencing / other audio visual means Pursuant to Regulation 44(3) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find attached the voting results on the business transacted at the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 at 3.00 PM IST through video conferencing / other audio visual means. Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find attached the Scrutinizer''s Report on the business transacted at the 17th Annual General Meeting of the Company held on Friday, 25th July 2025 through video conferencing / other audio visual means (As Per BSE Announcement Dated on: 25/07/2025) Please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12/08/2025)

EGM Date: 05 Feb 2024

Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about notice of Extra-Ordinary General Meeting (EGM) of the Company that will be held on Monday, 05th February,2024 at 4.00 PM through Video Conferencing/ other Audio Visual Means. Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the newspaper publication on the Notice of the Extra-Ordinary General Meeting of the Company that will be held on Monday on 05th February,2024, through VC/OAVM (As Per BSE Announcement Dated on 11.01.2024) Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Summary of the proceedings and Voting Results and Scrutinizers Report of the Extra-Ordinary General Meeting of the Company held on 05th February,2024 through VC/OAVM Sudarshan Pharma Industries Limited hereby intimates the Stock Exchange about the Summary of Proceedings and Voting Results and Scrutinizers Report of the Extra-Ordinary General Meeting held on 05th February,2024 through VC/OAVM (As Per BSE Announcement Dated on 06/02/2024) Sudarshan Pharma Industries Limited hereby clarifies the Stock Exchange that this submission of Proceedings of the EGM is not a delayed Submission but it is a reply to the query raised by the Stock Exchange. (As Per BSE Announcement dated on 19.02.2024)

EGM Date: 30 Sep 2024

EGM 30/09/2024 We enclose the Voting Results of the Extraordinary General Meeting of the Company held on Monday, 30th September 2024 at 5.00 pm through video conferencing / other audio visual means. An Extraordinary General Meeting of the Company is scheduled to be held on Monday, 30-September-2024 at 5.00 pm IST through video conferencing / other audio video means (As Per BSE Announcement Dated on: 05/09/2024) We enclose the Scrutinizer''s Report for the Extraordinary General Meeting of the Company held on Monday, 30th September 2024 at 5.00 pm through video conferencing / other audio visual means. (As Per BSE Announcement Dated on 01.10.2024) Please find enclosed the revised voting results on the business transacted at the Extraordinary General Meeting held on 30/09/2024 through video conferencing / other audio visual means, along with remote e-voting done by the members eligible to do so as per the Addendum issued by the Company as per the instructions of BSE Limited Please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting held on 30/09/2024 through video conferencing / other audio visual means along with remote e-voting done by the members eligible to do so as per the Addendum issued by the Company as per the instructions of BSE Limited. (As per BSE Announcement Dated on 21/11/2024)

EGM Date: 04 Feb 2025

Raising of funds by way of creating, issuing and allotting up to 4,30,00,000 (Four Crores Thirty Lakhs Only) Fully Convertible Warrants Convertible into equivalent number of fully paid-up equity shares of the Company having face value of Re.1/- (Rupee One Only), in one or more tranches, to the persons belonging to 'Promoter / Promoter Group and 'Non-Promoter, Public Category' Please find enclosed the newspaper publication for the Notice of Extraordinary General Meeting to be held on Tuesday, 04/February/2025 at 3.00 pm IST through video conferencing / other audio visual means published in (i) Mumbai Lakshdeep and (ii) Financial Express (As per BSE Announcement Dated on 14/01/2025) We inform you that an Extraordinary General Meeting of the Company was held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio visual means. Pursuant to Regulation 30 and part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a summary of the proceedings of Extraordinary General Meeting. (As Per BSE Announcement Dated on: 04/02/2025) Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Tuesday, 4th February 2025 at 3.00 pm through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on: 05/02/2025)

EGM Date: 12 Jun 2025

Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 please find enclosed the Notice of Extraordinary General Meeting to be held on 12/June/2025 at 3.00 pm IST through video conferencing / other audio visual means. Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 we enclose herewith the summary of the proceedings of the Extraordinary General Meeting of the Company held on 12th June 2025 at 3.00 p.m. through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12.06.2025) Pursuant to Regulation 44 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Scrutinizer''s Report on the business transacted at the Extraordinary General Meeting of the Company held on Thursday, 12th June 2025 through video conferencing / other audio-visual means. (As Per BSE Announcement Dated on :14.06.2025)

EGM Date: 11 Aug 2025

Pursuant to Regulation 34 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find enclosed the Notice of Extraordinary General Meeting to be held on 11/August/2025 at 1.00 p.m. IST through video conferencing / other audio visual means Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations And Disclosure REquirements) Regulations, 2015, we enclose herewith the summary of proceedings of Extraordinary General Meeting held on Monday, 11th August 2025 at 1.00 pm through video conferencing / other audio visual means. (As per BSE Announcement Dated on 11.08.2025) Please find enclosed the voting results on the business transacted at the Extraordinary General Meeting of the Company held on Monday, 11th August 2025 through video conferencing / other audio visual means. (As Per BSE Announcement Dated on: 12/08/2025)

Sudarshan Pharma Industries Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Pidilite Industries Ltd	₹1,498.80	₹1,52,544.17
SRF Ltd	₹2,658.95	₹78,817.88
Linde India Ltd	₹6,709.95	₹57,222.45
Gujarat Fluorochemicals Ltd	₹3,680.65	₹40,431.94
Navin Fluorine International Ltd	₹7,186.40	₹36,863.93

Sudarshan Pharma Industries Ltd Top Mutal Funds Invested

No data available

Sudarshan Pharma Industries Ltd News

Sudarshan Pharma Industries revises board meeting date

To 21 May 2026

19 May 2026, 02:12 pm

Sudarshan Pharma Industries to hold board meeting

On 15 May 2026

13 May 2026, 10:25 am

Sudarshan Pharma Industries schedules board meeting

On 30 April 2026

28 Apr 2026, 12:49 pm

Sudarshan Pharma Industries announces board meeting date

On 28 January 2026

23 Jan 2026, 10:47 am

Sudarshan Pharma Industries to announce Quarterly Result

On 18 October 2025

16 Oct 2025, 11:42 am

Sudarshan Pharma Industries Ltd Stock Analysis

Annual revenue for Sudarshan Pharma Industries Ltd increased by 7.92% to ₹505.38 crore in FY 2025 from ₹468.31 crore in FY 2024.
Annual Net Profit for Sudarshan Pharma Industries Ltd increased by 39.82% to ₹15.88 crore in FY 2025 from ₹11.36 crore in FY 2024.
Promoter Shareholding in Sudarshan Pharma Industries Ltd remains unchanged by 0.00% in the most recent quarter, from 57.39% in December 2025 to 57.39% in March 2026.
Sudarshan Pharma Industries Ltd delivered a 1-year return of 12.33% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Sudarshan Pharma Industries Ltd share price moved down by 0.20% from its previous close of INR ₹35.07. The latest Sudarshan Pharma Industries Ltd share price is INR ₹35.
Sudarshan Pharma Industries Ltd share price today has been at a low of 35 and a high of 35. Over the past 52 weeks, the Sudarshan Pharma Industries Ltd share price has seen a low of 18.50 and a high of 36.95.